Familial Mediterranean Fever (FMF)
15
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (15)
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases
Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases
Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
Comparing Structured Neuromuscular Exercise and Exergaming Program in Adolescents With Familial Mediterranean Fever
A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF
Physical Activity in Adolescents With Familial Mediterranean Fever
Investigation of the Validity, Reliability and Responsiveness of the BETY-BQ in FMF
Comparison of the Effects of Synchronous and Asynchronous Telerehabilitation in Patients with Juvenile Familial Mediterranean Fever
Barriers to Physical Activity in Familial Mediterranean Fever
Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System
Hematological Indices in Pediatric Diagnosed with Familial Mediterranean Fever
Gluten-related Disorders in Familial Mediterranean Fever Patients
The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever.